Dupixent 200 MG/1.14 ML pen 1.14ML
Ended Awarded
- Contract number
- SPE2DB25FQ2F9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,439
Award facts
- Contract value 100% obligated
- $12,439.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp, valued at $12,439.02, for the supply of Dupixent 200 mg/1.14 mL pen injections. The award was made on September 9, 2025, with an ultimate completion date of September 10, 2025, under a firm fixed-price delivery order contract type with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order represents a child contract issued under the company's larger federal contracting relationship with DLA.
This award falls under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive pharmaceutical supply agreement enabling the contractor to deliver a wide range of medications, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, with a demonstrated track record of competitively awarded contracts across multiple therapeutic domains. The Dupixent delivery supports the DLA Medical Supply Chain's ongoing need for specialty pharmaceutical products required by military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FQ2F9?
SPE2DB25FQ2F9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FQ2F9 worth?
The government has obligated $12,439 on SPE2DB25FQ2F9.
Is contract SPE2DB25FQ2F9 an order under another contract?
Yes. SPE2DB25FQ2F9 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FQ2F9 competed?
The extent of competition for SPE2DB25FQ2F9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award